Pleural effusions.
Identifieur interne : 006437 ( PubMed/Checkpoint ); précédent : 006436; suivant : 006438Pleural effusions.
Auteurs : C W TurtonSource :
- British journal of hospital medicine [ 0007-1064 ] ; 1980.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Agents alcoylants (administration et posologie), Asbestose (), Aspiration (technique), Défaillance cardiaque (), Embolie pulmonaire (), Femelle, Humains, Lymphoedème (), Maladie de Hodgkin (), Mâle, Ongles, Plèvre (), Pneumopathie infectieuse (), Ponction-biopsie à l'aiguille, Practolol (effets indésirables), Radio-isotopes (usage thérapeutique), Syndrome de Meigs, Tumeurs de la plèvre (), Tumeurs de la plèvre (secondaire), Épanchement pleural (), Épanchement pleural (diagnostic), Épanchement pleural (étiologie).
- MESH :
- administration et posologie : Agents alcoylants.
- diagnostic : Épanchement pleural.
- effets indésirables : Practolol.
- secondaire : Tumeurs de la plèvre.
- usage thérapeutique : Radio-isotopes.
- étiologie : Épanchement pleural.
- Adulte d'âge moyen, Asbestose, Aspiration (technique), Défaillance cardiaque, Embolie pulmonaire, Femelle, Humains, Lymphoedème, Maladie de Hodgkin, Mâle, Ongles, Plèvre, Pneumopathie infectieuse, Ponction-biopsie à l'aiguille, Syndrome de Meigs, Tumeurs de la plèvre, Épanchement pleural.
English descriptors
- KwdEn :
- Alkylating Agents (administration & dosage), Asbestosis (complications), Biopsy, Needle, Female, Heart Failure (complications), Hodgkin Disease (complications), Humans, Lymphedema (complications), Male, Meigs Syndrome, Middle Aged, Nails, Pleura (surgery), Pleural Effusion (diagnosis), Pleural Effusion (etiology), Pleural Effusion (therapy), Pleural Neoplasms (complications), Pleural Neoplasms (secondary), Pneumonia (complications), Practolol (adverse effects), Pulmonary Embolism (complications), Radioisotopes (therapeutic use), Suction.
- MESH :
- chemical , administration & dosage : Alkylating Agents.
- chemical , adverse effects : Practolol.
- complications : Asbestosis, Heart Failure, Hodgkin Disease, Lymphedema, Pleural Neoplasms, Pneumonia, Pulmonary Embolism.
- diagnosis : Pleural Effusion.
- etiology : Pleural Effusion.
- secondary : Pleural Neoplasms.
- surgery : Pleura.
- chemical , therapeutic use : Radioisotopes.
- therapy : Pleural Effusion.
- Biopsy, Needle, Female, Humans, Male, Meigs Syndrome, Middle Aged, Nails, Suction.
Abstract
Pleural effusions develop following changes in capillary permeability, capillary hydrostatic pressure, plasma colloid osmotic pressure, or lymphatic drainage. Generalized fluid retention or a transudate suggests a systemic cause while an exudate suggests a local cause. The diagnosis can usually be established by clinical assessment, chest radiography, analysis of pleural fluid, pleural biopsy, and appropriate special investigations. When no cause can be found, particular care should be taken to exclude secondary carcinoma, tuberculosis, pulmonary infarction, and mesothelioma; the patient should be followed-up. Symptomatic malignant effusions may be managed initially by basal intercostal tube drainage alone. For recurrences, local instillation first of tetracycline and then of mustine may be tried. Pleurectomy should be considered if the prognosis is otherwise good.
PubMed: 6991044
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:6991044Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pleural effusions.</title><author><name sortKey="Turton, C W" sort="Turton, C W" uniqKey="Turton C" first="C W" last="Turton">C W Turton</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1980">1980</date><idno type="RBID">pubmed:6991044</idno><idno type="pmid">6991044</idno><idno type="wicri:Area/PubMed/Corpus">006E35</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">006E35</idno><idno type="wicri:Area/PubMed/Curation">006E35</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">006E35</idno><idno type="wicri:Area/PubMed/Checkpoint">006E35</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">006E35</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Pleural effusions.</title><author><name sortKey="Turton, C W" sort="Turton, C W" uniqKey="Turton C" first="C W" last="Turton">C W Turton</name></author></analytic><series><title level="j">British journal of hospital medicine</title><idno type="ISSN">0007-1064</idno><imprint><date when="1980" type="published">1980</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alkylating Agents (administration & dosage)</term><term>Asbestosis (complications)</term><term>Biopsy, Needle</term><term>Female</term><term>Heart Failure (complications)</term><term>Hodgkin Disease (complications)</term><term>Humans</term><term>Lymphedema (complications)</term><term>Male</term><term>Meigs Syndrome</term><term>Middle Aged</term><term>Nails</term><term>Pleura (surgery)</term><term>Pleural Effusion (diagnosis)</term><term>Pleural Effusion (etiology)</term><term>Pleural Effusion (therapy)</term><term>Pleural Neoplasms (complications)</term><term>Pleural Neoplasms (secondary)</term><term>Pneumonia (complications)</term><term>Practolol (adverse effects)</term><term>Pulmonary Embolism (complications)</term><term>Radioisotopes (therapeutic use)</term><term>Suction</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Agents alcoylants (administration et posologie)</term><term>Asbestose ()</term><term>Aspiration (technique)</term><term>Défaillance cardiaque ()</term><term>Embolie pulmonaire ()</term><term>Femelle</term><term>Humains</term><term>Lymphoedème ()</term><term>Maladie de Hodgkin ()</term><term>Mâle</term><term>Ongles</term><term>Plèvre ()</term><term>Pneumopathie infectieuse ()</term><term>Ponction-biopsie à l'aiguille</term><term>Practolol (effets indésirables)</term><term>Radio-isotopes (usage thérapeutique)</term><term>Syndrome de Meigs</term><term>Tumeurs de la plèvre ()</term><term>Tumeurs de la plèvre (secondaire)</term><term>Épanchement pleural ()</term><term>Épanchement pleural (diagnostic)</term><term>Épanchement pleural (étiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Alkylating Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Practolol</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Agents alcoylants</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Asbestosis</term><term>Heart Failure</term><term>Hodgkin Disease</term><term>Lymphedema</term><term>Pleural Neoplasms</term><term>Pneumonia</term><term>Pulmonary Embolism</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Pleural Effusion</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Épanchement pleural</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Practolol</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Pleural Effusion</term></keywords><keywords scheme="MESH" qualifier="secondaire" xml:lang="fr"><term>Tumeurs de la plèvre</term></keywords><keywords scheme="MESH" qualifier="secondary" xml:lang="en"><term>Pleural Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Pleura</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Radioisotopes</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Pleural Effusion</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Radio-isotopes</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Épanchement pleural</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Biopsy, Needle</term><term>Female</term><term>Humans</term><term>Male</term><term>Meigs Syndrome</term><term>Middle Aged</term><term>Nails</term><term>Suction</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Asbestose</term><term>Aspiration (technique)</term><term>Défaillance cardiaque</term><term>Embolie pulmonaire</term><term>Femelle</term><term>Humains</term><term>Lymphoedème</term><term>Maladie de Hodgkin</term><term>Mâle</term><term>Ongles</term><term>Plèvre</term><term>Pneumopathie infectieuse</term><term>Ponction-biopsie à l'aiguille</term><term>Syndrome de Meigs</term><term>Tumeurs de la plèvre</term><term>Épanchement pleural</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Pleural effusions develop following changes in capillary permeability, capillary hydrostatic pressure, plasma colloid osmotic pressure, or lymphatic drainage. Generalized fluid retention or a transudate suggests a systemic cause while an exudate suggests a local cause. The diagnosis can usually be established by clinical assessment, chest radiography, analysis of pleural fluid, pleural biopsy, and appropriate special investigations. When no cause can be found, particular care should be taken to exclude secondary carcinoma, tuberculosis, pulmonary infarction, and mesothelioma; the patient should be followed-up. Symptomatic malignant effusions may be managed initially by basal intercostal tube drainage alone. For recurrences, local instillation first of tetracycline and then of mustine may be tried. Pleurectomy should be considered if the prognosis is otherwise good.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">6991044</PMID><DateCreated><Year>1980</Year><Month>08</Month><Day>25</Day></DateCreated><DateCompleted><Year>1980</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0007-1064</ISSN><JournalIssue CitedMedium="Print"><Volume>23</Volume><Issue>3</Issue><PubDate><Year>1980</Year><Month>Mar</Month></PubDate></JournalIssue><Title>British journal of hospital medicine</Title><ISOAbbreviation>Br J Hosp Med</ISOAbbreviation></Journal><ArticleTitle>Pleural effusions.</ArticleTitle><Pagination><MedlinePgn>239-40, 244, 246-7 passim</MedlinePgn></Pagination><Abstract><AbstractText>Pleural effusions develop following changes in capillary permeability, capillary hydrostatic pressure, plasma colloid osmotic pressure, or lymphatic drainage. Generalized fluid retention or a transudate suggests a systemic cause while an exudate suggests a local cause. The diagnosis can usually be established by clinical assessment, chest radiography, analysis of pleural fluid, pleural biopsy, and appropriate special investigations. When no cause can be found, particular care should be taken to exclude secondary carcinoma, tuberculosis, pulmonary infarction, and mesothelioma; the patient should be followed-up. Symptomatic malignant effusions may be managed initially by basal intercostal tube drainage alone. For recurrences, local instillation first of tetracycline and then of mustine may be tried. Pleurectomy should be considered if the prognosis is otherwise good.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Turton</LastName><ForeName>C W</ForeName><Initials>CW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Hosp Med</MedlineTA><NlmUniqueID>0171545</NlmUniqueID><ISSNLinking>0007-1064</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000477">Alkylating Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011868">Radioisotopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>SUG9176GRW</RegistryNumber><NameOfSubstance UI="D011217">Practolol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000477" MajorTopicYN="N">Alkylating Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001195" MajorTopicYN="N">Asbestosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001707" MajorTopicYN="N">Biopsy, Needle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006689" MajorTopicYN="N">Hodgkin Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008539" MajorTopicYN="N">Meigs Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009262" MajorTopicYN="N">Nails</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010994" MajorTopicYN="N">Pleura</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010996" MajorTopicYN="N">Pleural Effusion</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010997" MajorTopicYN="N">Pleural Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011217" MajorTopicYN="N">Practolol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011868" MajorTopicYN="N">Radioisotopes</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013396" MajorTopicYN="N">Suction</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>40</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1980</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1980</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1980</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">6991044</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Turton, C W" sort="Turton, C W" uniqKey="Turton C" first="C W" last="Turton">C W Turton</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006437 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 006437 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:6991044
|texte= Pleural effusions.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:6991044" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |